Philippe Moerman
Overview
Explore the profile of Philippe Moerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Salihi R, Leunen K, Moerman P, Amant F, Neven P, Vergote I
Int J Gynecol Cancer
. 2017 Jun;
27(6):1256-1260.
PMID: 28574931
Objective: Neoadjuvant chemotherapy (NACT) followed by surgery in cervical cancer is widely studied with paclitaxel-ifosfamide-cisplatinum 3 weekly (TIP). Although the response rates with TIP are high, the toxicity is substantial....
12.
Van Rompuy A, Vanderstichele A, Vergote I, Moerman P
Int J Gynecol Pathol
. 2017 May;
37(3):290-295.
PMID: 28463910
Mucinous (goblet cell) carcinoids are a rare type of ovarian carcinoid tumors. Only a limited number of primary mucinous carcinoids of the ovary have been reported in the literature. We...
13.
Delattre S, Han S, Moerman P, Billen J, Goffin F, Scharpe K, et al.
Gynecol Obstet Invest
. 2017 Mar;
83(1):76-82.
PMID: 28329740
Background/aims: We updated human chorionic gonadotropin (hCG) regression curves created in the eighties after evacuation of complete and partial molar (CM and PM, respectively) pregnancies using modern hCG assays. We...
14.
Cuppens T, Annibali D, Coosemans A, Trovik J, Ter Haar N, Colas E, et al.
Clin Cancer Res
. 2017 Feb;
23(5):1274-1285.
PMID: 28232476
Uterine sarcomas are rare and heterogeneous tumors characterized by an aggressive clinical behavior. Their high rates of recurrence and mortality point to the urgent need for novel targeted therapies and...
15.
Koskas M, Depreeuw J, Moens S, Annibali D, Cuppens T, Moerman P, et al.
Anticancer Res
. 2016 Nov;
36(10):5381-5384.
PMID: 27798902
Background/aim: Human epidermal growth factor receptor 2 (HER2) positivity is associated with a worse prognosis in endometrial cancer (EC). Trastuzumab as a single agent did not demonstrate activity in such...
16.
Michielsen K, Vergote I, Dresen R, Op de Beeck K, Vanslembrouck R, Amant F, et al.
Br J Radiol
. 2016 Sep;
89(1067):20160468.
PMID: 27585490
Objective: To assess the clinical feasibility of whole-body diffusion-weighted MRI (WB-DWI/MRI) for diagnosis and prediction of complete tumour resection in patients with suspected recurrent ovarian cancer. Methods: 51 females clinically...
17.
Vancraeynest E, Moerman P, Leunen K, Amant F, Neven P, Vergote I
Int J Gynecol Cancer
. 2016 Jul;
26(8):1399-406.
PMID: 27465897
Objectives: This study aimed to determine the overall survival (OS) and progression-free interval and the influence of fertility-preserving surgery (FPS) versus radical surgery (RS) in patients with serous borderline ovarian...
18.
Roosing S, Romani M, Isrie M, Rosti R, Micalizzi A, Musaev D, et al.
J Med Genet
. 2016 May;
53(9):608-15.
PMID: 27208211
Background: Ciliopathies are an extensive group of autosomal recessive or X-linked disorders with considerable genetic and clinical overlap, which collectively share multiple organ involvement and may result in lethal or...
19.
Moerman P, Amant F, Vergote I
Int J Surg Pathol
. 2016 Apr;
24(7):635-9.
PMID: 27098588
This article describes the case of a 70-year-old woman with an adnexal cystadenocarcinoma located in the right broad ligament and displaying a striking resemblance to a well-differentiated endometrioid adenocarcinoma. The...
20.
Szafranski P, Gambin T, Dharmadhikari A, Akdemir K, Jhangiani S, Schuette J, et al.
Hum Genet
. 2016 Apr;
135(5):569-586.
PMID: 27071622
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a lethal lung developmental disorder caused by heterozygous point mutations or genomic deletion copy-number variants (CNVs) of FOXF1 or its...